Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $321,537 - $446,515
-4,435 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $93,398 - $128,391
1,035 Added 30.44%
4,435 $423,000
Q2 2021

Aug 16, 2021

BUY
$93.66 - $139.27 $159,222 - $236,759
1,700 Added 100.0%
3,400 $423,000
Q1 2021

May 14, 2021

BUY
$116.57 - $155.01 $11,657 - $15,501
100 Added 6.25%
1,700 $224,000
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $159,376 - $227,392
1,600 New
1,600 $212,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.77B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Baldwin Investment Management, LLC Portfolio

Follow Baldwin Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Investment Management, LLC with notifications on news.